Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment.

Zareba, Wojciech; Krawiec, Piotr; Banaszkiewicz, Malgorzata; Batko, Krzysztof; Golab, Aleksandra; Plicner, Dariusz; Zuber, Zbigniew; Batko, Bogdan

Zareba, Wojciech; Krawiec, Piotr; Banaszkiewicz, Malgorzata; Batko, Krzysztof; Golab, Aleksandra; Plicner, Dariusz; Zuber, Zbigniew; Batko, Bogdan.

Afiliação

Zareba W; Department of Cardiology, Jozef Dietl Specialist Hospital, Krakow, Poland.
Krawiec P; Department of Rheumatology and Immunology, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University, Krakow, Poland.
Banaszkiewicz M; Department of Research and Development, Medicine Economy Law Science Foundation (MELS), Krakow, Poland.
Batko K; Department of Nephrology and Transplantology, Jagiellonian University Medical College, Krakow, Poland.
Golab A; Department of Research and Development, Medicine Economy Law Science Foundation (MELS), Krakow, Poland.
Plicner D; Department of Nephrology and Transplantology, Jagiellonian University Medical College, Krakow, Poland.
Zuber Z; Faculty of Medicine and Dentistry, Pomeranian Medical University in Szczecin, Poland.
Batko B; Unit of Experimental Cardiology and Cardiac Surgery, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University, Krakow, Poland.

Reumatologia ; 61(6): 424-431, 2023.

Article em En | MEDLINE | ID: mdl-38322099

Palavras-chave

biologic treatment; cardiovascular disease; hypertension; lipid disorders; rheumatoid arthritis; risk factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Reumatologia Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google